Volume 1, Issue 4 (Autumn 2020)                   J Vessel Circ 2020, 1(4): 29-34 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghafuri Y, Izanloo H, Mohebi S, Saghafipour A, Karami Joushin M, Karimi Matloub S. Prevalence of Hypertension and Its Associated Car-diovascular Disease-Induced Mortality. J Vessel Circ 2020; 1 (4) :29-34
URL: http://jvessels.muq.ac.ir/article-1-67-en.html
1- Research Center for Environmental Pollutants, Qom University of Medical Sciences, Qom, Iran., Qom uniersitiy
2- Department of Health Education and Promotion, Faculty of Health, Qom University of Medical Sciences, Qom, Iran.
3- Department of Health Education and Promotion, Faculty of Health, Qom University of Medical Sciences, Qom, Iran., Qom uniersitiy
Full-Text [PDF 831 kb]   (316 Downloads)     |   Abstract (HTML)  (1293 Views)
Full-Text:   (442 Views)
1. Introduction
Hypertension is a common but asymptomatic complication; it is easily identifiable and treatable. If left untreated, 50% of patients with hypertension will die from coronary artery disease or heart failure; approximately 33% from stroke, and about 10%-15% from kidney failure. However, with proper treatment of hypertension, these complications can be prevented [1]. Hypertension is the major risk factor for cardiovascular stroke and affects one in 4 adults [2]. The World Health Organization estimates that at least one billion individuals worldwide have hypertension, and approximately 7.1 million subjects die from the disease, annually [3]. About 73% of deaths in 2015 were due to non-communicable diseases; of which, 48% were due to cardiovascular diseases [4]. In 2010, in Iran, about 92000 deaths were related to heart attacks and strokes, which accounted for 39% of all deaths [5, 6]. Hypertension is a major health problem in developed and developing countries. This is because of its high prevalence in the population and its association with cardiovascular stroke and chronic renal diseases. In industrialized countries, 25% of adults and 60% of individuals aged over 60 years encounter hypertension [7]. Approximately two-thirds of strokes and half of all ischemic heart disease are attributed to systolic blood pressure above 115 mm Hg [8]. Due to the increasing trend of hypertension in Iran, its high prevalence, and its modifiability as a risk factor for cardiovascular disease, it is essential to identify the prevalence pattern of hypertension. Therefore, this study explored the prevalence of hypertension and the attributable contribution of mortality due to cardiovascular diseases associated with hypertension.
2. Materials and Methods
The present cross-sectional study examined about 15% of the population aged >30 years, including 72836 middle-aged and elderly referring to the comprehensive healthcare service centers for treating hypertension in Qom Province, Iran, from 2017 to 2019. Considering that information related to blood pressure measurement in the SIB system (integrated health system) and the electronic health record of individuals is recorded in healthcare centers and databases, the required data were collected per the instructions of the care package of the Ministry of Health and Medical Education under the title of IraPen (Package of Essential Noncommunicable Disease Iran) Care Program [9]. To increase the accuracy and validity of the study, the process of correct implementation according to the IraPen protocol was periodically monitored by the experts of the healthcare center. This study considered the following ranges: healthy blood pressure: (>120/80), pre-hypertension (120/80-139/89), and hypertension (≥140/90). Moreover, to determine the fraction attributable to the population (PAF), i.e., a proportion of the incidence of the disease in the population and is attributed to a risk factor, the relation PAF=P* [(1-RRadj)/RRadj] was used; the prevalence of P and RRadj is the relative risk of hypertension in the incidence of cardiovascular disease mortality, i.e., indirectly achievable due to the study type, of similar study results based on hazard ratio, i.e., a more accurate relative risk estimate. In the cited studies, the predominant effects of influential variables (other than hypertension) on mortality due to cardiovascular diseases, including age, gender, diabetes, smoking, and moderate obesity, have been reported [10-12]. In this study, Excel and SPSS v. 16 were used to classify, describe, and analyze the obtained data.
3. Results
Tables 1 and 2 present the frequency of hypertension in the examined population aged over 30 years by age, gender, and place of residence, as well as fraction attributed to hypertension in the mortality of middle-aged and elderly population in Qom Province. Furthermore, Figures 1 and 2 illustrate systolic blood pressure distribution and diastolic blood pressure in the explored sample during the study period.
4. Discussion
The current study results indicated that 62.6% (95%CI: 62.1-63.1) of the examined clients presented healthy blood pressure, 21.2% (95%CI: 19.4-22) pre-hypertension, and 16.2% (95%CI: 15.9-16.4) presented hypertension. Besides, 29% of the total mortality due to cardiovascular diseases occurred in the elderly and 4% in the middle-aged groups due to hypertension. In this study, controlling hypertension decreased in middle-aged patients, compared to elderly patients as well as in men, compared to women (P<0.001). Additionally, 74% of the study patients with hypertension in urban areas, compared to 84% in rural areas presented controlled blood pressure; this difference was significant in the mentioned groups (P<0.001). In this study, the prevalence of hypertension in the group aged over 30 years was determined to be 16.2%. These results were consistent with those of the review study by Mohsenzadeh et al. in Iran and Eghbali et al. in Isfahan; however, they were inconsistent with the results of the Golestan Cohort study [13-15]. In the review study by Afsargharehbagh et al. in 2018, the prevalence of hypertension in Iran was reported to be 20.4% [16]. In a meta-analysis in 2019, Jafari Oori et al. reported the prevalence of hypertension in Iran as 25% of the total population and 42% of the elderly population. This finding was in line with those of the current research concerning the elderly; however, this condition has a low prevalence in the general population [17]. In the national study of risk factors for non-communicable diseases in Iran, in 2011, the prevalence of hypertension was reported to be 25% [18]. In this study, the Mean±SD values of systolic blood pressure and diastolic blood pressure were 118±22 mm Hg and 74±13 mm Hg, respectively. In the national survey of non-communicable disease risk factors in 2011 by Esteghamati et al., the mean systolic and diastolic blood pressures were measured as 123 mm Hg and 79 mm Hg, respectively, suggesting differences with the present study results [18].
 Based on the study of controlled hypertension in Isfahan, Jahrom, Hormozgan, and most recent domestic studies, this rate has been reported as 79%, i.e., higher than that in the current study in Qom Province. This difference could be attributed to increased healthcare, diagnostic, and treatment measures in recent years in Qom Province [15, 19, 20]. In the present study, the control of hypertension in urban areas was significantly less than that in rural areas; therefore, easy access to healthcare services, proximity and sufficient awareness among the rural population about the existence of free hypertension care services, and the avoidance of urban stressors seem to be influential. In this study, 8.5% and 29% of cardiovascular disease-induced deaths in individuals aged >30 and ≥60 years were attributed to hypertension, respectively. A similar study in Urmia reported a population attributable to hypertension death from ischemic heart disease in the age group of 25-64 years in men as 14.4% and women as 18.6% [21]. A critical reason for the low proportion of the population in this study could be the relatively low prevalence of hypertension, compared to the same study in Urmia.
5. Conclusion
 The present research findings revealed that the prevalence of hypertension in Qom Province is lower than in the national average. The obtained data supported the attributable share of mortality due to cardiovascular diseases associated with hypertension in Qom Province. Considering that hypertension is a controllable risk factor as well as the limited health resources (financial, manpower), to reduce mortality due to this disease, educational interventions in the target populations should be considered by health policymakers in the province.
Ethical Considerations
Compliance with ethical guidelines
There were no ethical considerations to be considered in this research.
Funding
This research did not receive any grant from funding agencies in the public, commercial, or non-profit sectors.
Authors' contributions
Conceptualization and supervision: Moharram Karami Joushin and Yadollah Ghafuri; Methodology: Hasan Izanloo, Abedin Saghafipur; Investigation, writing and data collection: Siamak Mohebi and Saeed Karimi.
Conflict of interest
The authors declared no conflicts of interest.
Acknowledgments
The authors appreciate all the healthcare providers of Healthcare Centers in Qom Province, Iran, who were involved in caring for patients with hypertension and collecting and registering the information of these patients in the SIB system.



 
Type of Study: Research | Subject: cardiovascular diseases
Received: 2020/03/2 | Accepted: 2020/04/26 | Published: 2020/10/1

References
1. [1] Azizi F, Hatami H, Jonghorbani M. [Epidemiology and control disease in Iran (Persian)]. Tehran: Eshtiagh Publication; 2000. http://opac.nlai.ir/opac-prod/bibliographic/617745
2. [2] Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, et al. National, regional, and global trends in systolic blood pressure since 1980: Systematic analysis of health examination surveys and epidemiological studies with 786 countryyears and 5ยท4 million participants. Lancet. 2011; 377(9765):568-77. [DOI:10.1016/S0140-6736(10)62036-3] [DOI:10.1016/S0140-6736(10)62036-3]
3. [3] World Health Organization. The World Health report: 2002: Reducing risks, promoting healthy life [Internet]. 2002 [Updated 2002]. Available from: https://apps.who.int/iris/handle/10665/67454
4. [4] Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28(1):1-39.e14. [DOI:10.1016/j.echo.2014.10.003] [PMID] [DOI:10.1016/j.echo.2014.10.003]
5. [5] Azizi F. [Prevening NCDS: Improving lifestyle an inevitable necessity (Persian)]. Pejouhesh dar Pezeshki (Res Med). 2003; 27(4):261-3. https://pejouhesh.sbmu.ac.ir/browse.php?a_id=64&sid=1&slc_lang=fa
6. [6] World Health Organization. Global status report on noncommunicable diseases 2014 [Internet]. 2014 [Updated 2014]. Available from: https://apps.who.int/iris/handle/10665/148114
7. [7] Azizi A, Abasi MR, Abdoli GR. [The prevalence of hypertension and its association with age, sex and BMI in a population being educated using community-based medicine in Kermanshah: 2003 (Persian)]. Iran J Endocrinol Metab. 2008; 10(4):323-9. http://ijem.sbmu.ac.ir/article-1-578-en.html
8. [8] Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL, Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002; 360(9343):1347-60. [DOI:10.1016/S0140-6736(02)11403-6] [PMID] [DOI:10.1016/S0140-6736(02)11403-6]
9. [9] World Health Organization. WHO Package of Essential NCD Interventions (WHO PEN) for primary care in low-resource settings: Essential technologies and medicines and risk prediction tools. In: World Health Organization. Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low Resource Settings. Geneva: World Health Organization; 2010. pp. 35-42. https://www.who.int/nmh/publications/essential_ncd_interventions_lr_settings.pdf
10. [10] Fahimfar N, Khalili D, Mohebi R, Azizi F, Hadaegh F. Risfactors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran. BMC Neurol. 2012; 12:117 [DOI:10.1186/1471-2377-12-117] [PMID] [PMCID] [DOI:10.1186/1471-2377-12-117]
11. [11] Lotfaliany M, Akbarpour S, Mozafary AH, Rajab Boloukat R, Azizi F, Hadaegh F. Hypertension phenotypes and incident cardiovascular disease and mortality events in a decade followup of a Middle East cohort. J Hypertens. 2015; 33(6):1153-61. [DOI:10.1097/HJH.0000000000000540] [PMID] [DOI:10.1097/HJH.0000000000000540]
12. [12] Khalili D, Haj Sheikholeslami F, Bakhtiyari M, Azizi F, Momenan AA, Hadaegh F. The incidence of coronary heart disease and the population attributable fraction of its risk factors in Tehran: A 10-year population-based cohort study. PloS One. 2014;9(8):e105804 [DOI:10.1371/journal.pone.0105804] [PMID] [PMCID] [DOI:10.1371/journal.pone.0105804]
13. [13] Malekzadeh MM, Etemadi A, Kamangar F, Khademi H, Golozar A, Islami F, et al. Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens. 2013; 31(7):1364-71. [DOI:10.1097/HJH.0b013e3283613053] [PMID] [PMCID] [DOI:10.1097/HJH.0b013e3283613053]
14. [14] Mohsenzadeh Y, Motedayen M, Hemmati F, Sayehmiri K, Sarokhani MT, Sarokhani D. Investigating the prevalence rate of hypertension in Iranian men and women: A study of systematic review and meta-analysis. J Basic Res Med Sci. 2017;4(1):53-62. [DOI:10.18869/acadpub.jbrms.4.1.53] [DOI:10.18869/acadpub.jbrms.4.1.53]
15. [15] Eghbali M, Khosravi AR, Feizi A, Mansouri A, Mahaki B, Sarrafzadegan N. Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: A crosssectional study in Iran. Epidemiol Health. 2018; 40:e2018020. [DOI:10.4178/epih.e2018020] [PMID] [PMCID] [DOI:10.4178/epih.e2018020]
16. [16] Afsargharehbagh R, Rezaie-Keikhaie Kh, Rafiemanesh H, Balouchi A, Bouya S, Dehghan B. Hypertension and pre-hypertension among Iranian adults population: A meta-analysis of prevalence, awareness, treatment, and control. Curr Hypertens Rep. 2019; 21(4):27. [DOI:10.1007/s11906-019-0933-z] [PMID] [DOI:10.1007/s11906-019-0933-z]
17. [17] Jafari Oori M, Mohammadi F, Norozi K, Fallahi-Khoshknab M, Ebadi A, Ghanei Gheshlagh R. Prevalence of HTN in Iran: Meta-analysis of published studies in 2004-2018. Curr Hypertens Rev. 2019; 15(2):113-22. [DOI:10.2174/1573402115666190118142818] [PMID] [PMCID] [DOI:10.2174/1573402115666190118142818]
18. [18] Esteghamati AR, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie AP, Khajeh E, et al. Awareness, treatment and control of pre-hypertension and hypertension among adults in Iran. Arch Iran Med. 2016; 19(7):456-64. [PMID]
19. [19] Aghamolaei T, Hossaini FS, Farshidi H, Madani A, Ghanbarnejad A. [Lifestyle of patients with high blood pressure in rural areas of Jahrom, Iran (Persian)]. J Prev Med. 2014; 1(1):1-9. http://jpm.hums.ac.ir/article-1-35-en.html
20. [20] Mostafavi H, Zare N, Dabghmanesh MH. [Blood pressure levels, risk factors and hypertension control status in adult population of Shiraz (Persian)]. Hormozgan Med J. 2007;11(1):43-51. https://hmj.hums.ac.ir/Article/89106
21. [21] Ahangari T, Masudi S, Salarilak Sh. [Mortality attributable to high blood pressure for cardiovascular diseases in the West Azerbaijan province 25-64 years old population (Persian)]. Med J Tabriz Univ Med Sci. 2019; 40(6):7-13. https://mj.tbzmed.ac.ir/Article/23990

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Vessels and Circulation

Designed & Developed by : Yektaweb